|
Aakash Exploration
|
|
|
|
H e m a n g N H a r i a has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
|
|
Accretion Pharma.
|
|
|
|
The Exchange has sought clarification from Accretion Pharmaceuticals Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. The company has not submitted declaration in case of unmodified opinion(s) The response of the Company is awaited.
|
|
|
Accuracy Shipping
|
|
|
|
Accuracy Shipping Limited has informed the Exchange about Copy of Newspaper Publication of Postal Ballot Notice.
|
|
|
Ace Integrated Solut
|
|
|
|
The Exchange has sought clarification from Ace Integrated Solutions Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
|
|
|
Aeron Composite
|
|
|
|
Chirag Chandulal Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
|
|
Aesthetik Engineers
|
|
|
|
The Exchange has sought clarification from Aesthetik Engineers Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Segment details not submitted The response of the Company is awaited.
|
|
|
Ajooni Biotech
|
|
|
|
Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on July 01, 2025.
|
|
|
Alembic Pharma
|
|
|
|
The Exchange has sought clarification from Alembic Pharmaceuticals Ltd on July 01, 2025, with reference to Movement in Volume. The reply is awaited.
|
|
|
Ameya Precision Engg
|
|
|
|
The Exchange had sought clarification from Ameya Precision Engineers Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
|
|
|
Aspinwall & Co
|
|
|
|
Aspinwall and Company Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
|
|
|
|
|